PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
申请人:Astrazeneca AB
公开号:EP3670499A1
公开(公告)日:2020-06-24
The present application relates to novel compounds of formula (I)
to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.
本申请涉及式 (I) 的新型化合物
在治疗和/或预防包括心血管疾病 (CVD) 在内的临床病症方面的用途、治疗方法、含有这些化合物的药物组合物以及制备这些化合物的工艺。